INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. It focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. It has two operational INVO Centers in the United States and one IVF clinic. It is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Company Information
About this company
Key people
Steven M. Shum
Chief Executive Officer, Director
Terah Krigsvold
Chief Financial Officer
Andrea Goren
Chief Business Officer
Daniel Teper
Director
Trent Davis
Independent Director
Rebecca Messina
Independent Director
Barbara A. Ryan
Independent Director
Matthew K. Szot
Independent Director
Click to see more
Key facts
- Shares in issue2.39m
- EPICIVF
- ISINUS44984F8077
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$2.55m
- Employees28
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.